SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001367644-22-000057
Filing Date
2022-03-25
Accepted
2022-03-25 15:17:14
Documents
3
Period of Report
2022-03-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_164823581935777.html 3  
1 FORM 3 wf-form3_164823581935777.xml 3 2316
2 GLESSNER POA 2 a20220317glessnerpoa.htm EX-24 637
3 GLESSNER POA 2 GRAPHIC a20220317glessnerpoa001.jpg GRAPHIC 235474
  Complete submission text file 0001367644-22-000057.txt   328766
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Issuer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 400 PROFESSIONAL DRIVE SUITE 400 GAITHERSBURG MD 20879
Business Address
Glessner Coleen (Reporting) CIK: 0001919170 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33137 | Film No.: 22770884